QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-is-robotic-surgery-focused-penny-stock-asensus-surgical-trading-higher-on-friday

KARL STORZ Endoscopy-America has agreed to acquire Asensus Surgical for $0.35 per share, representing a 67% premium. This acqui...

 karl-storz-to-acquire-all-outstanding-shares-of-asensus-surgical-for-035-per-share-in-cash

KARL STORZ to acquire Asensus for $0.35 per share in cash Creating a leading surgical robotics division within KARL STORZRESEAR...

 hc-wainwright--co-reiterates-neutral-on-asensus-surgical-maintains-035-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Asensus Surgical (AMEX:ASXC) with a Neutral and maintains ...

 asensus-surgical-q1-adj-007-misses-005-estimate-sales-112m-miss-120m-estimate

Asensus Surgical (AMEX:ASXC) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0....

 wayfair-to-rally-over-28-here-are-10-top-analyst-forecasts-for-thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 hc-wainwright--co-downgrades-asensus-surgical-to-neutral-lowers-price-target-to-035

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Asensus Surgical (AMEX:ASXC) from Buy to Neutral and lower...

 hc-wainwright--co-maintains-buy-on-asensus-surgical-maintains-2-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Asensus Surgical (AMEX:ASXC) with a Buy and maintains $2 pr...

 asensus-surgical-q4-eps-007-beats-008-estimate-sales-543m-beat-530m-estimate

Asensus Surgical (AMEX:ASXC) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08...

 earnings-scheduled-for-march-21-2024

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per s...